SCHEMBL7206345

SCHEMBL7206345

CC(C)c1[c]c(C(C)C)c(C(=O)Cc2c(C(C)C)cccc2C(C)C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.41
GABRG2 P18507 2/20 0.41
GABRB3 P28472 2/20 0.41
LPAR1 Q92633 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.34
LMNA P02545 2/20 0.33
FAAH O00519 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
GABRB1 P18505 1/20 0.33
PTGS1 P23219 1/20 0.33
SLC6A2 P23975 1/20 0.33
HTR2C P28335 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33
HTR2B P41595 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7206924 0.88 SOAT2 (0.39) GABRA1GABRB2SOAT2MYCSOAT1
SCHEMBL7212856 0.86 AKR1B1 (0.41) LMNACYP3A4HPGDHTR2CHTR2B
SCHEMBL7206954 0.81 SRD5A2 (0.34) GABRA1GABRG2GABRB3TSHR
SCHEMBL7206388 0.81 TSHR (0.41) SMN1; SMN2LMNAHPGDTSHRHIF1A
SCHEMBL7206905 0.81 NPC1 (0.30) SMN1; SMN2KMT2AMEN1
SCHEMBL7207810 0.77 SMN1; SMN2 (0.41) SMN1; SMN2LMNACYP3A4HPGDKMT2A
SCHEMBL7206347 0.77 GABRA1 (0.43) GABRA1GABRG2GABRB3LPAR1SMN1; SMN2
SCHEMBL7212819 0.75 TTR (0.53) SMN1; SMN2LMNAHPGDTSHRHIF1A
SCHEMBL7109320 0.75 FABP3 (0.35) SOAT2MYCSOAT1MAP2K3
SCHEMBL7206377 0.74 LMNA (0.37) SMN1; SMN2LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0841913-B1 USE OF SULFAMIC ACID DERIVATIVES, ACYL SULFONAMIDES OR SULFONYL CARBAMATES FOR THE MANUFACTURE OF A MEDICAMENT FOR LOWERING LIPOPROTEIN LEVELS WARNER LAMBERT CO (US) 2003-02-05 EP claimed